Insight Lifetech Co., Ltd.

¥29.00As of Sun 8 Nov 2026, 12:00 UTC
SSE:688712Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE 9.76%
Medical Devices
Beta (5Y) —
PE TTM 87.46
TSR TTM —
Mkt cap ¥12.09B
ROIC 22.19%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥33
14.55%
(88.01%)
Hold 0|8|6|4|12
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.33
0.33
0.34
0.36
16.24%
7.95%
12.51%
15.10%
Revenue¥M
641.4
637.9
650.9
645.4
(1.42%)
0.80%
4.76%
4.03%
Peers (US$1.813B)
Cap (US$)
PE
1.952B
42.28x
1.590B
18.21x
1.810B
60.86x
Capital
TTM
5Y
10Y
Leveragex
1.440
0.071
0.065
EBIT/Intx
1.400
0.432
0.333
Own earn%
80.17
(58.74)
(56.14)
Sh yield%
56.31
16.63
18.57
Owners
Insiders/Inst%
2.42
68.59
Short interest%
5.20
SBC / revenue%
0.44
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
2
Op margin range%
7–11
$1 testx
—
Incr. ROIC%
7